One of the world’s top selling drugs potentially also acts
against the growth of new lymphatic vessels, with potential implications for
cancer therapy. This surprising finding was brought forward by researchers at
ETH Zurich with their newly developed three-dimensional cell culture system.
Researchers at the Institute of Pharmaceutical Sciences at
ETH Zurich and the University of California Berkeley have made an unexpected
discovery. Their search for novel pharmaceuticals that might prevent the
generation of tumour metastases and transplant rejection identified a
well-known drug class: the statins.